Navigation Links
New ACO Reinsurance Program Launched by Star Line Group, U.S. Advisors and Ascendent Care
Date:11/8/2011

MINNEAPOLIS, Nov. 8, 2011 /PRNewswire/ -- Star Line Group, U.S. Advisors and Ascendent Care, announced today a new reinsurance program in response to the final regulations published recently by CMS for the Medicare ACO Shared Savings Program.

"We recognize the unique requirements of organizations that want to participate in the ACO Shared Savings Program and their need to moderate their downside risk in an affordable fashion," notes Robert Tierney, Star Line President.  "We have been tracking this issue from the draft regulations and our team has been working on the development of this new program for a number of months."

The ACO Reinsurance program recognizes the delayed cash flow compared to traditional health care financing mechanisms, as well as other unique aspects of the Shared Savings Program.  It is designed to protect an ACO's capital as they take risk on Medicare members.  

"Our reinsurance program really takes a lot of pressure off the downside risk and the cash flow requirements of the ACO," notes Terry Chesser, President of U.S. Advisors. 

"We have studied the environment closely and believe that we have an ideal program for those ACOs who have the motivation to improve quality and efficiency, yet may not have the deepest balance sheets and would otherwise not be able to take advantage of the Track 2 profit sharing rewards,"  explains Dan Johnson, Star Line Vice President.  

Mike Barrett, CEO of Ascendent Care, further adds "Ascendent is pleased to be involved in the due diligence review of ACOs under consideration for reinsurance, as well as the ongoing reporting and monitoring activities.  It is clear that this will expand the number of organizations that can step up to meet the mission and goals of the Medicare ACO Shared Savings Program."

ACOs interested in learning more about the reinsurance program should contact Terry Chesser, U.S. Advisors at (615) 263-5901 or via email at tchesser@advisorsus.com.

Star Line Group is a leading specialty underwriting manager for Specialty Benefits, Stop Loss and Managed Care insurance and reinsurance. For more information on Star Line, visit www.starlinegroup.com or contact Dan Johnson at (612) 455-8333 or djohnson@starlinegroup.com.

U.S. Advisors is an independently owned and operated reinsurance broker/consultant dedicated solely to the Managed Care Industry with clients nationally. For more information on U.S. Advisors, visit www.advisorsus.com or contact Principals Terry Chesser at (615) 263-5901 or tchesser@advisorsus.com. Or, Richard Polay at (727) 823-4577 or rpolay@advisorsus.com

Ascendent Care is a consulting firm supporting provider organizations in their efforts to integrate and improve care with change management, care process redesign, infrastructure and capital development programs. For more information on Ascendent Care, visit www.ascendentcare.com or contact Mike Barrett directly at (321) 263-5076 or mbarrett@ascendentcare.com.  

Primary Contact:
Terry Chesser
tchesser@advisorsus.com
615-263-5901


'/>"/>
SOURCE Star Line Group
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. NephroGenex Reaches Agreement with the FDA on a Subpart H Phase 3 Program for Pyridorin™
2. Karyopharm Therapeutics Closes $10 Million Series A2 Financing to Expand Planned Phase 1 Program of Oral Selective Inhibitors of Nuclear Export (SINE) for Cancer
3. "PATH B": A Comprehensive Support Programme in Europe for Patients Diagnosed With Chronic Hepatitis B Launched
4. ViiV Healthcare Starts Phase III Clinical Programme of Celsentri/Selzentry® (maraviroc) versus Truvada® (tenofovir + FTC), in combination with a Protease Inhibitor in people living with HIV
5. United Therapeutics Announces Proposed Private Offering of $210 Million of Convertible Senior Notes and Authorization of Stock Repurchase Program
6. United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program
7. Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match®
8. Novo Nordisk and Atlanta Area Organizations Partner on Diabetes Education Programs
9. PharmAthene Achieves Significant Progress in SparVax™ Anthrax Vaccine Program
10. BD Biosciences Announces Winners of Research Grant Program
11. University of Houston receives NSF grant for high school teachers program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" ... Liver Congress ("ILC") 2017 of the European Association for the ... on the positive effects of PBI-4050 on reduction of ... metabolic syndrome. ... Dr. Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic "This ...
(Date:4/20/2017)... , April 20, 2017 Dutch philosopher Koert van ... ,Next Nature, at the University of Technology in Eindhoven - has written ... this letter, he calls on humanity to avoid becoming a slave and victim ... ... Dutch philosopher Koert van Mensvoort – founder of the ...
(Date:4/19/2017)... ... April 18, 2017 , ... A number of new instruments ... which is part of the Protein and Cell Analysis Education Webinar Series , ... this technology fits in current and future applications. , Many flow cytometers have ...
(Date:4/19/2017)... ... April 19, 2017 , ... ThermaGenix, the PCR Improvement Company, ... to several other early achievements at ThermaGenix, including the business formation and licensing ... ThermaGenix will use proceeds from the Series A-1 round to:, ...
Breaking Biology Technology:
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
Breaking Biology News(10 mins):